86.94
+0.73%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About IRadimed
From its filings with the US Securities and Exchange Commission
IRadimed is based in Orlando, Florida and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker IRMD. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $83.8m and net income of $22.5m. At that date it held total assets of $108.8m and shareholders' equity of $94.6m.
IRADIMED CORPORATION (“IRadimed”, the “Company,” “we,” “us,” “our” or similar terms) develops, manufactures, markets and distributes Magnetic Resonance Imaging (“MRI”) compatible medical devices and related accessories, disposables and services relating to them. We were originally incorporated in Oklahoma under the name IRI Development, Inc. in 1992, and we merged our Oklahoma corporation into the newly formed Delaware corporation, IRADIMED CORPORATION, in April 2014.
We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use during MRI procedures and operates dependably in magnetic fields up to 15,000 gauss. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium 3870 MRI Compatible IV Infusion Pump System, introduced in 2025, has been designed with a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, touch screen user interface, and other special features to safely and predictably deliver anesthesia and other critical care IV fluids during various MRI procedures.
Quoted from its 10-K, filed 6 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 16 Jul 2014
- Employees
- 166
- Website
- iradimed.com/en-us ↗
- Head office
- 12705 INGENUITY DRIVE, ORLANDO, FL, 32826
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Roger SusiChairman of the Board, President, Chief Executive Officer, Founder, since 2020$689,580
- Mr. John GlennChief Financial Officer, Corporate Secretary$1.3m
- Mr. Randy WaddellVice President - Worldwide Sales and Marketing$597,277
- Mr. Jeffrey ChiprinChief Commercial Officer$388,683
- Mr. James HawkinsDirector, since 2013$149,950
- Mr. Monty AllenIndependent Director$169,950
- Mr. Joe KianiIndependent Director
- Ms. Hilda Scharen-GuivelIndependent Director$162,450
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 26
- Environment
- 28
- Social
- 30
- Governance
- 19
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Strong technological expertise and innovative product portfolio.
- Established reputation and brand recognition in the medical devices industry.
- Robust distribution network enabling global reach.
Weaknesses
- Limited product diversification, primarily focused on MRI-compatible infusion pumps.
- Relatively small market presence compared to larger competitors.
- Dependent on key suppliers for critical components.
Opportunities
- Growing demand for MRI-compatible medical devices due to increasing prevalence of chronic diseases.
- Expansion into emerging markets with untapped potential.
- Collaborations and partnerships to enhance product offerings.
Threats
- Intense competition from larger medical device manufacturers.
- Stringent regulatory requirements and compliance costs.
- Technological advancements by competitors may render current product offerings obsolete.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.